Public health issues related to infection in pregnancy and cerebral palsy

Mental Retardation and Developmental Disabilities Research Reviews
Diana E SchendelPoul Thorsen

Abstract

Cerebral palsy is the most common neuromotor developmental disability of childhood, affecting as many as 8,000 to 12,000 children born in the U.S. each year (corresponding to a prevalence rate of between 2 and 3 per 1000 children). Recent improvements in neonatal care have not resulted in a decline in the overall prevalence of cerebral palsy and, in fact, greater numbers of very preterm/very low birth weight infants are surviving with cerebral palsy and other developmental problems. Infection in pregnancy may be an important cause of the disorder. In preterm infants, there appears to be about a 2-fold increased risk for cerebral palsy from chorioamnionitis, and in term infants the estimated increased risk is about 4-fold. Provisionally, chorioamnionitis might account for 12% of spastic cerebral palsy in term infants and 28% of cerebral palsy in preterm infants. Studies of biochemical markers of fetal inflammation typically associated with infection also suggest that an inflammatory response may be an important independent etiologic factor. If a substantial proportion of cerebral palsy is attributable to acute amnionitis infection and/or neonatal sepsis, cerebral palsy should have decreased in the United States after administrat...Continue Reading

References

Jun 1, 1992·Developmental Medicine and Child Neurology·L MutchM V Perat
May 1, 1991·British Journal of Obstetrics and Gynaecology·H M McDonaldP J McDonald
Feb 1, 1990·Archives of Disease in Childhood·R W Cooke
Nov 1, 1990·American Journal of Obstetrics and Gynecology·J A McGregorJ K Todd
Apr 1, 1988·The Journal of Pediatrics·E Blair, F J Stanley
Jun 26, 1986·The New England Journal of Medicine·K M Boyer, S P Gotoff
Oct 10, 1986·JAMA : the Journal of the American Medical Association·M G GravettK K Holmes
Oct 1, 1985·American Journal of Diseases of Children·K B Nelson, J H Ellenberg
Apr 1, 1994·Obstetrics and Gynecology·M K YanceyP Duff
Aug 1, 1993·The Journal of Pediatrics·S K CumminsE M Velie
Jan 1, 1996·Obstetrics and Gynecology·R B KundsinS A Poulin
Apr 1, 1996·American Journal of Obstetrics and Gynecology·J A ReganR Edelman
Mar 1, 1996·American Journal of Obstetrics and Gynecology·M D PearlmanW Solomon
Mar 1, 1996·The Journal of Pediatrics·J K GretherS K Cummins
Jun 1, 1997·Archives of Pediatrics & Adolescent Medicine·W C AllanL R Ment
Jul 16, 1997·JAMA : the Journal of the American Medical Association·J K Grether, K B Nelson
Aug 21, 1997·The New England Journal of Medicine·Z A BrownL Corey
Jan 15, 1998·The New England Journal of Medicine·B S McEwen
Feb 7, 1998·Archives of Pediatrics & Adolescent Medicine·T A JosephN Jacobs
Mar 21, 1998·American Journal of Epidemiology·T M O'SheaR G Dillard
Aug 15, 1998·American Journal of Obstetrics and Gynecology·R RomeroS M Berry
Aug 15, 1998·American Journal of Obstetrics and Gynecology·R GomezS M Berry
Oct 20, 1998·Annals of Neurology·K B NelsonT M Phillips
Oct 28, 1998·American Journal of Obstetrics and Gynecology·C V TowersT Asrat
Nov 5, 1999·Obstetrics and Gynecology·M E HagenseeD H Martin
Jan 6, 2000·The New England Journal of Medicine·S J SchragA Schuchat
Apr 14, 2000·Current Opinion in Pediatrics·O Dammann, A Leviton
May 18, 2000·The New England Journal of Medicine·R L GoldenbergW W Andrews
Jun 28, 2000·American Journal of Obstetrics and Gynecology·A L NelsonD Oliak
Aug 22, 2000·Archives of Disease in Childhood·A Johnson
Sep 16, 2000·JAMA : the Journal of the American Medical Association·Y W Wu, J M Colford

❮ Previous
Next ❯

Citations

Oct 31, 2002·Journal of Neuroscience Research·Michael J Bell, John M Hallenbeck
Nov 28, 2002·Mental Retardation and Developmental Disabilities Research Reviews·Claudine Amiel-TisonJeannette Rogowski
Apr 24, 2004·Reproductive Biology and Endocrinology : RB&E·Mahmoud HuleihelMordechai Hallak
Apr 13, 2011·Pediatrics·Bryan S MichalowiczPanos N Papapanou
Feb 10, 2006·Disability and Rehabilitation·Else OddingHendrik J Stam
Jul 11, 2006·Seminars in Fetal & Neonatal Medicine·Michal A Elovitz
Dec 14, 2004·American Journal of Obstetrics and Gynecology·Cynthia J HolcroftErnest M Graham
Aug 13, 2013·The Journal of Pediatrics·Mary D Crisham JanikYvonne W Wu
Oct 24, 2014·Frontiers in Pediatrics·Jason M RosenzweigIrina Burd
Sep 30, 2015·BioMed Research International·Eveline StrackxAntonio W D Gavilanes
Apr 11, 2019·Physiology·Joline E BrandenburgGary C Sieck
Feb 12, 2020·International Journal of Environmental Research and Public Health·Md Habibur RahmanMohammad Ali Moni
Feb 22, 2008·Brain Research·Aditi SharangpaniMichael J Bell
Sep 23, 2021·Asia-Pacific Journal of Public Health·Shahnaz H IbrahimZulfiqar A Bhutta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.